A randomized controlled trial on combining therapeutic patient education with standard care versus standard care alone for chronic migraine: Effects on patient-reported outcome measures
Abstract
Background Therapeutic patient education (TPE) has been understudied for the management of chronic migraine (CM). Objective To study the effects of TPE with standard of care (SOC) versus SOC alone on patient-related outcome measures (PROM) in CM. Methods CM patients who were not on any preventive drugs for the past 3 months, aged 18–65 years, were randomized to receive TPE with SOC versus SOC alone and followed up for 12 weeks. TPE was imparted by a medical student following a rigorous 4-week training program by two senior headache specialists. TPE was imparted in the form of interactive group sessions lasting at least 20 minutes every 2 weeks. Patients in the control group received only SOC and instructions on dosing. The primary endpoint was the change in the Migraine-Specific Quality of Life (MSQOL) scores at Week 12. The key secondary outcomes were changes in the Headache Impact Test-6 (HIT-6) and Migraine Disability Assessment (MIDAS) scores at Week 12. Other secondary endpoints were also assessed. Efficacy analyses were performed in a modified intention-to-treat population who had at least one follow-up visit at Week 4. The trial was registered with the Clinical Trial Registry of India (CTRI/2022/06/04361). Results One hundred twenty-six patients were randomized. One hundred and seventeen patients (57 in the treatment and 60 in the control group) were available for the final efficacy analysis. The treatment group, compared with the control, showed a significant…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.